Tamiflu and Relenza linked to abnormal behavior in some patients
Source: MSN News
Government health regulators recommended adding label precautions about neurological problems seen in children who have taken flu drugs made by Roche and GlaxoSmithKline.
The Food and Drug Administration on Friday released its safety review of Roche’s Tamiflu and Glaxo’s Relenza. Next week, an outside group of pediatric experts is scheduled to review the safety of several such drugs when used in children.
FULL STORY
improve the quality of human life by enabling people to do more, feel better and live longer.
No comments: